Table 1:
Phoenix Antibiotic Susceptibility Panel Interpretation.
| Antibiotic | MIC (ug/mL) | Interpretation | Number of isolates that are resistant | |
|---|---|---|---|---|
| Amikacin | 8–32 | <8 S | >32R | 38 (80.85%) |
| Gentamicin | 2–8 | <2S | >8R | 44 (93.61%) |
| Ertapenem | 0.25–4 | <0.25S | >4R | 47 (100%) |
| Imipenem | 1–8 | <1S | >8R | 47 (100%) |
| Meropenem | 1–8 | <1S | >8R | 47 (100%) |
| Cephalothin | 4–16 | <4S | >16R | 47 (100%) |
| Cefuroxime | 4–16 | <4S | >16R | 47 (100%) |
| Cefoxitin | 4–16 | <4S | >16R | 47 (100%) |
| Ceftazidime | 1–16 | <1S | >16R | 47 (100%) |
| Ceftriaxone | 1–32 | <1S | >32R | 47 (100%) |
| Cefepime | 1–16 | <1S | >16R | 47 (100%) |
| Aztreonam | 2–16 | <2S | >16R | 45 (95.74%) |
| Ampicillin | 4–16 | <4S | >16R | 47 (100%) |
| Amoxicillin / Clavulanate | 4/2–16/8 | <4/2S | >16/8R | 47 (100%) |
| Piperacillin / Tazobactam | 4/4–64/4 | <4/4S | >64/4R | 47 (100%) |
| Colistin | 1–4 | <1S | >4R | 0 (0%) |
| Trimethoprim / Sulfamethoxazole | 1/19–4/76 | <1/19S | >4/76R | 47 (100%) |
| Nitrofurantoin | 16–64 | <16S | >64R | 47 (100%) |
| Ciprofloxacin | 0.5–2 | <0.5S | >2R | 39 (82.97%) |
| Levofloxacin | 1–4 | <1S | >4R | 39 (82.97%) |
| Tigecycline | 1–4 | <1S | >4R | 47 (100%) |
S: Sensitive, R: Resistant